|
| [12] | T. Püngel, S. De Vos, J. Hundertmark, M. Kohlhepp, N. Guldiken, P. Pujuguet, M. Auberval, F. Marsais, K. F. Shoji, L. Saniere, C. Trautwein, T. Lüdde, P. Strnad, R. Brys, P. Clément-Lacroix, F. Tacke,
"The medium-chain fatty acid receptor gpr84 mediates myeloid cell infiltration promoting steatohepatitis and fibrosis", Journal of Clinical Medicine, vol. 9, no. 4, 2020, pp. 1140.
|
|
| [11] | N. Guldiken, J. Argemi, B. Gurbuz, S. R. Atkinson, M. Oliverius, P. Fila, K. Hamesch, T. Bruns, J. Cabezas, J. J. Lozano, J. Mann, S. Cao, P. Mathurin, V. H. Shah, C. Trautwein, M. R. Thursz, R. Bataller, P. Strnad,
"Serum transferrin as a biomarker of hepatocyte nuclear factor 4 alpha activity and hepatocyte function in liver diseases", BMC medicine, vol. 19, 2021, pp. 39.
|
| [10] | D. Heinrichs, E. F. Brandt, P. Fischer, J. Köhncke, T. Wirtz, N. Guldiken, S. Djudjaj, P. Boor, D. C. Kroy, R. Weiskirchen, R. Bucala, H. E. Wasmuth, P. Strnad, C. Trautwein, J. Bernhagen, M. Berres,
"Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations", Cells, vol. 10, no. 2, 2021, pp. 252.
|
| [9] | C. V. Schneider, M. Kleinjans, M. Fromme, K. M. Schneider, P. Strnad,
"Phenome-wide association study in adult coeliac disease", Alimentary pharmacology & therapeutics, vol. 53, no. 4, 2021, pp. 510–518.
|
| [8] | C. V. Schneider, M. Fromme, K. M. Schneider, T. Bruns, P. Strnad,
"Mortality in Patients With Genetic and Environmental Risk of Liver Disease", The American journal of gastroenterology, vol. 116, no. 8, 2021, pp. 1741–1745.
|
| [7] | J. Voss, C. V. Schneider, M. Kleinjans, T. Bruns, C. Trautwein, P. Strnad,
"Hepatobiliary phenotype of individuals with chronic intestinal disorders", Scientific reports, vol. 11, 2021, pp. 19954.
|
|
| [6] | S. R. Atkinson, M. Aly, K. Remih, L. D. Tyson, N. Guldiken, R. Goldin, A. Quaglia, M. Thursz, P. Strnad,
"Serum keratin 19 (CYFRA21-1) is a prognostic biomarker in severe alcoholic hepatitis", Liver international, vol. 42, no. 5, 2022, pp. 1049–1057.
|
| [5] | M. Fromme, C. V. Schneider, C. Schlapbach, S. Cazzaniga, C. Trautwein, D. J. Rader, L. Borradori, P. Strnad,
"Comorbidities in lichen planus by phenome‐wide association study in two biobank population cohorts", British journal of dermatology, vol. 187, no. 5, 2022, pp. 722–729.
|
| [4] | M. Kleinjans, C. V. Schneider, T. Bruns, P. Strnad,
"Phenome of coeliac disease vs. inflammatory bowel disease", Scientific reports, vol. 12, 2022, pp. 14572.
|
| [3] | P. Strnad, M. Mandorfer, G. Choudhury, W. Griffiths, C. Trautwein, R. Loomba, T. Schluep, T. Chang, M. Yi, B. D. Given, J. C. Hamilton, J. San Martin, J. H. Teckman,
"Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency", The New England journal of medicine, vol. 387, no. 6, 2022, pp. 514–524.
|
|
| [2] | B. Gurbuz, N. Guldiken, P. Reuken, L. Fu, K. Remih, C. Preisinger, R. Brůha, M. Leníček, J. Petrtýl, J. Reißing, M. Aly, M. Fromme, B. Zhou, I. Karkossa, K. Schubert, M. von Bergen, A. Stallmach, T. Bruns, P. Strnad,
"Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis", Hepatology international, vol. 17, no. 3, 2023, pp. 698–708.
|
| [1] | M. Ruiz, F. Lacaille, C. Schrader, M. Pons, P. Socha, A. Krag, E. Sturm, M. Bouchecareilh, P. Strnad,
"Pediatric and adult liver disease in alpha1-antitrypsin deficiency", Seminars in liver disease, 2023, pp. 32 Seiten.
|